Pharmaceutical & Life Sciences News

Insulin Makers, PBMs to Testify Before House Panel Next Week

April 2, 2019, 5:51 PM

Three insulin manufacturers and the three biggest pharmacy benefit managers will be in Washington next week for a hearing before the House Energy and Commerce’s oversight subcmte, according to Democratic Rep. Diana DeGette, chairwoman of the subcmte.

  • NOTE: Panel subcmte held a hearing earlier today entitled: “Priced Out of a Lifesaving Drug: The Human Cost of Rising Insulin Prices”, that included patient advocates
  • Cmte says Eli Lilly, Novo Nordisk and Sanofi are the three insulin manufacturers that serve the U.S. market while CVS Health, Express Scripts and UnitedHealth are the three PBMs that cover about 70% of all prescription claims...
To read the full article log in. To learn more about a subscription click here.